The Defense Threat Reduction Agency (DTRA) Cooperative Threat Reduction (CTR) Biological Threat Reduction Program (BTRP) protects the United States, its Armed Forces, and our allies from biological threats by strengthening the capabilities of partner nations and the international community to prevent, detect, and prepare for disease outbreaks. BTRP supports international health security efforts to address diseases caused by U.S. Biological Select Agents (https://www.cdc.gov/selectagent/SelectAgentsandToxinsList.html), pathogens of pandemic potential, and emerging (and reemerging) infectious diseases. BTRP achieves its mission through collaboration with partner countries and the international community to minimize the threat of deliberate, accidental, and natural infectious disease outbreaks through enhanced detection, diagnosis, and reporting capabilities and biosecurity and biosafety measures. This Broad Agency Announcement (BAA) is an extramural endeavor that seeks to bring funding to biosurveillance studies that support biosecurity and biosafety (BS&S) capability building, in-country partnerships, and other needs appropriate to meet BTRP’s mission interests.
BTRP utilizes international engagements to promote science and technical collaborations with partner nations, regional and international organizations, and the global scientific community to foster and maintain ethical, constructive, and sustainable partnerships that address health security threats. In addition to increasing the knowledge and mitigation of risks posed by potential disease causing pathogens and approaches that build effective capacities and capabilities to reduce those risks, these projects are intended to develop strong international relationships through technical assistance that will enhance the ability of partner nations to contribute to global disease awareness and improve their domestic public health posture. Scientific studies evaluated and awarded through the BAA are one part of comprehensive country and regional engagements BTRP develops and maintains. Projects are designed to be relevant, cooperative, impactful, and contributory to enduring capabilities. There is a strong preference for science projects that are multi-sectoral/multi-institutional, build upon prior BTRP investments, and facilitate cooperation and transparency with local, national, regional, and/or international partners. Additionally, BTRP encourages that projects supported through the BAA be coordinated with activities from other U.S. government, academic, and international organizations programs.
This BAA is open continuously from 29 April 2024 through 28 April 2029 . Submissions aligning to the BTRP mission, general topic areas, and LOEs may occur at any time this BAA is in effect. Applicants should take care to note requirements and timelines for submitting Abstracts, White Papers, and Full Proposals.
Abstracts, White Papers, and Full Proposals submitted for the BAA will be considered from the following U.S. and foreign institutions as follows:
• Accredited degree-granting colleges, universities, and academic institutions.
• Industrial and commercial entities, including small businesses.
• Not-for-profit entities with a portfolio predominantly in research and foreign government laboratories. Proof of 501(c)(3) status from the Internal Revenue Service may be required. For foreign-based establishments entirely based outside the U.S. and/or its territories, proof of not-for-profit status may be required. Foreign based government laboratory equivalents include (but are not limited to) those residing in a country’s Ministry of Defense, Ministry of Health, Ministry of Agriculture, Ministry of Education and Science and Food Safety Agencies.
Eligible Countries:
Sponsor Institute/Organizations: Department of Defense
Address: 1400 Defense Pentagon; Washington, DC 20301-1400;United States
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Apr 28, 2029
Varies
Affiliation: Department of Defense
Address: 1400 Defense Pentagon; Washington, DC 20301-1400;United States
Website URL: https://www.grants.gov/search-results-detail/343725
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.